---
title: "Ibrance (palbociclib), all indications: Indication questions"
description: "Indication questions on Ibrance (palbociclib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is the generic name of Ibrance? 1 question quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/ibrance/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ibrance (palbociclib), all indications: Indication questions

Manufacturer: Pfizer Laboratories Div Pfizer Inc  
Prescribing information: [Ibrance](https://labeling.pfizer.com/ShowLabeling.aspx?id=12921), [Ibrance](https://labeling.pfizer.com/ShowLabeling.aspx?id=2191)  
Indication pages: [HR-positive HER2-negative advanced or metastatic breast cancer](https://www.evicenter.com/medical-information/ibrance--hr-positive-her2-negative-advanced-or-metastatic-breast-cancer)

## Drug names

<a id="ibrance-generic-name"></a>

### What is the generic name of Ibrance?

> “IBRANCE® (palbociclib) tablets, for oral use”

Source: [IBRANCE: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=12921#:~:text=IBRANCE%C2%AE%20%28palbociclib%29%20tablets%2C%20for%20oral%20use)

> “IBRANCE® (palbociclib) capsules, for oral use”

Source: [IBRANCE: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=2191#:~:text=IBRANCE%C2%AE%20%28palbociclib%29%20capsules%2C%20for%20oral%20use)

> “IBRANCE tablets for oral administration contain 125 mg, 100 mg, or 75 mg of palbociclib, a kinase inhibitor.”

Source: [IBRANCE: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=12921#:~:text=IBRANCE%20tablets%20for%20oral%20administration,of%20palbociclib%2C%20a%20kinase%20inhibitor.)

## Related pages
- [Medical information: Ibrance (palbociclib): All indications](https://www.evicenter.com/medical-information/ibrance)
- [Pharmacology](https://www.evicenter.com/medical-information/ibrance/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/ibrance/safety)
- [Specific populations](https://www.evicenter.com/medical-information/ibrance/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/ibrance/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/ibrance/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/ibrance/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/ibrance/access-and-coverage)
